| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| INSM | Insmed Incorporated | 6.47% | 6,703,484 | $965,368,731 | -1,009,416 | -13.09% | $144.01 | 13F |
| TRDA | Entrada Therapeutics, Inc. | 0.29% | 4,691,392 | $42,550,925 | -174,427 | -3.58% | Form 4 | |
| GPCR | Structure Therapeutics Inc. | 0.29% | 1,556,109 | $43,571,052 | -952,658 | -37.97% | $28 | 13F |
| CERS | Cerus Corporation | 0.11% | 10,008,345 | $15,913,269 | -2,875,499 | -22.32% | $1.59 | 13F |
| KALA | KALA BIO, Inc. | 0.00793% | 744,759 | $1,146,929 | -240,334 | -24.40% | 13G | |
| CTNM | Contineum Therapeutics, Inc. | 0.00612% | 77,670 | $912,623 | -234,830 | -75.15% | $11.75 | 13F |